Pictet Asset Management
TERN

Pictet Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Pictet Asset Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,655,575
Closed -$87.3M – 2201
2026
Q1 		$87.3M Buy
1,655,575
+78,459
+5% +$3.22M 0.09% 230
2025
Q4 		$63.7M Buy
1,577,116
+472,912
+43% +$10.9M 0.06% 286
2025
Q3 		$8.29M Buy
+1,104,204
New +$7.05M 0.01% 708

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pictet Asset Management's TERN Position: Q2 2026 in Review

Pictet Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,655,575 shares — an estimated $87.3M sold.

Pictet Asset Management first reported a position in TERN in Q3 2025 and held it in 3 quarters. The position peaked at $87.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Pictet Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 1,655,575 Terns Pharmaceuticals shares in Q2 2026, an estimated $87.3M.
  • Pictet Asset Management first reported a position in Terns Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Pictet Asset Management's Terns Pharmaceuticals position peaked at $87.3M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.